A United Kingdom supplier, with 2 awarded contracts, totalling £16.2m, most recently 6 months ago.
This contract is based on a framework agreement with a single company, covering the supply of exclusive medications used in healthcare facilities of the Andalusian Health Service. The contract specifies the conditions for successive deliveries and unit pricing of these medications. The total value o
This contract involves the supply of exclusive medicines containing the active ingredients nivolumab, ipilimumab, abatacept, fedratinib, mavacamten, deucravacitinib, and azacitidine in tablet form. The buyer is the Murcian Health Service, and the total value of the contract is approximately €15,206,
